Improving outpatient care for patients undergoing chemotherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates whether enhanced outpatient symptom management using telemedicine and remote monitoring can reduce acute care visits caused by chemotherapy-related adverse events. Patients will be randomized into two groups: one receiving standard oncology care via telemedicine and the other receiving the same care along with remote monitoring. The study aims to evaluate the efficacy of remote patient monitoring on clinical outcomes and assess patient-centered outcomes such as quality of life and treatment delays.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (≥ 18 years)
* English- and Spanish-fluent participants with thoracic and/or gastrointestinal cancers who are scheduled to initiate or continue outpatient chemotherapy at either MDACC (Texas Medical Center campus and any Houston-area location) or MDACC oncology clinic at Lyndon B Johnson (LBJ) hospital
* Their adult (≥18 years) patient-identified or self-identified primary caregivers (MDACC only)
* Participants on combination chemotherapy and immunotherapy or combination chemotherapy and biologic will also be eligible for inclusion.
* Participants may participate if they do not have a caregiver, or if their caregiver declines participation; however, caregivers of MDACC participants may participate only if the participant consents.

Exclusion Criteria:

* Participants who are receiving investigational new drug treatments or concurrently enrolled in a phase 1 clinical trial will be excluded due to the associated structured reporting and regulatory requirements.
* Participants with a requirement for inpatient infusion (i.e. CAR-T cell therapy), living in institutional settings (i.e. prison, nursing homes), with a history of dementia, physical disability or neurological deficits that prohibit ability to report symptom burden will also be excluded.

Where it's running

• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Ryan W Huey, MD — M.D. Anderson Cancer Center
• Study coordinator: Ryan W Huey, MD
• Email: remotemonitoringprogram@mdanderson.org
• Phone: 713-792-2828

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using radiation therapy to treat metastatic gastrointestinal cancers

  This study tests if adding radiation therapy to immunotherapy can help people with metastatic gastrointestinal cancers feel better and improve their disease status.

  Recruiting University of California, San Francisco · San Francisco, California and 1 other locations · NCT04221893

• Real-time imaging of tumor blood vessels during surgery

  We will test whether a real-time microscope technique during surgery can show how well blood vessels in adults' solid tumors work and whether that helps predict if systemic cancer medicines can reach the tumor.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT03823144

• BMS-986504 plus pemetrexed for MTAP-deleted metastatic solid tumors

  This study tests whether the combination of BMS-986504 and pemetrexed is safe and potentially effective for people with MTAP-deleted metastatic solid tumors.

  Recruiting Phase 1/2 Northwestern University · Chicago, Illinois · NCT07594626

• Personalized vaccine combined with pembrolizumab for advanced solid tumors

  This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.

  Recruiting Phase 1/2 Mayo Clinic · Jacksonville, Florida · NCT05269381

• Using pressurized aerosol chemotherapy to treat advanced abdominal cancers

  This study is testing a new way to deliver chemotherapy directly into the abdomen using a special aerosol spray to see if it helps people with advanced abdominal cancers feel better and have fewer side effects.

  Recruiting at 2 sites Phase 1 City of Hope Medical Center · Duarte, California and 2 other locations · NCT04329494

• Using a high fiber product to reduce chemotherapy-related diarrhea in colon cancer patients

  This study is testing whether a high fiber product can help people with metastatic colon cancer reduce diarrhea caused by chemotherapy.

  Recruiting at 10 sites Phase 2 Rutgers, The State University of New Jersey · Hamilton, New Jersey and 9 other locations · NCT05296681

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.